Quick Takeaways
- BIOTECHNOLOGY VALUE FUND L P filed SCHEDULE 13G/A for CytomX Therapeutics, Inc. Common Stock, $0.00001 par value per share (CTMX).
- Disclosed ownership: 6.8%.
- Date of event: 30 Jun 2025.
Quoteable Key Fact
"BIOTECHNOLOGY VALUE FUND L P disclosed 6.8% ownership in CytomX Therapeutics, Inc. Common Stock, $0.00001 par value per share (CTMX) on 30 Jun 2025."
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original Filing| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| BIOTECHNOLOGY VALUE FUND L P | 3.8% | 6,148,026 | 0 | 6,148,026 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | |
| BVF I GP LLC | 3.8% | 6,148,026 | 0 | 6,148,026 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | |
| BIOTECHNOLOGY VALUE FUND II LP | 2.9% | 4,702,892 | 0 | 4,702,892 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | |
| BVF II GP LLC | 2.9% | 4,702,892 | 0 | 4,702,892 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | |
| Biotechnology Value Trading Fund OS LP | 0.3% | 541,232 | 0 | 541,232 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | |
| BVF Partners OS Ltd. | 0.3% | 541,232 | 0 | 541,232 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | |
| BVF GP HOLDINGS LLC | 6.4% | 10,850,918 | 0 | 10,850,918 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | |
| BVF PARTNERS L P/IL | 6.8% | 11,538,462 | 0 | 11,538,462 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | |
| BVF INC/IL | 6.8% | 11,538,462 | 0 | 11,538,462 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | |
| LAMPERT MARK N | 6.8% | 11,538,462 | 0 | 11,538,462 | /s/ Mark N. Lampert | Mark N. Lampert |